Reply to the Letter to the Editor concerning 'High levels of the soluble programmed death-ligand identify hepatocellular carcinoma patients with a poor prognosis'

Eur J Cancer. 2017 Jan:71:119-120. doi: 10.1016/j.ejca.2016.10.027. Epub 2016 Dec 15.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • B7-H1 Antigen*
  • Carcinoma, Hepatocellular*
  • Humans
  • Ligands
  • Liver Neoplasms
  • Prognosis

Substances

  • B7-H1 Antigen
  • Ligands